الأصول تغيير تاريخ
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 96.05B 409M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Daiichi Sankyo JPY 4.26T 144.08B 2026-09
Exelixis USD 2.51B 19.26M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
Incyte USD 7.29B 585.39M 2026-09
MacroGenics USD 318.68M 26.72M 2026-09
Moderna USD 13.47B 2.51B 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Takeda JPY 15.27T 391.77B 2026-09
TG Therapeutics USD 1.59B 47.38M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09